Elastase-Positive Neutrophils Are Associated With Refractoriness of Chronic Rhinosinusitis With Nasal Polyps in an Asian Population.

Allergy Asthma Immunol Res

Department of Otorhinolaryngology-Head and Neck Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Published: January 2020

AI Article Synopsis

  • The study explores the role of neutrophils in chronic rhinosinusitis with nasal polyps (CRSwNP) among an Asian population, focusing on factors that contribute to disease refractoriness.
  • Researchers analyzed the protein levels of neutrophil-related mediators in nasal polyps and conducted various tests to categorize types of nasal polyps based on eosinophil and neutrophil presence.
  • Findings revealed that tissue neutrophilia is a significant risk factor for CRSwNP refractoriness, with certain cytokines and proteins being linked to either effective disease control or persistent symptoms.

Article Abstract

Purpose: Various immune cells, including eosinophils and neutrophils, are known to contribute to the development of chronic rhinosinusitis with nasal polyps (CRSwNP). However, the current understanding of the role of neutrophils in the development of CRSwNP still remains unclear. Therefore, we investigated risk factors for refractoriness of CRSwNP in an Asian population.

Methods: Protein levels of 17 neutrophil-related mediators in nasal polyps (NPs) were determined by multiplex immunoassay, and exploratory factor analysis using principal component analysis was performed. Immunofluorescence analysis was conducted to detect human neutrophil elastase (HNE) or myeloperoxidase (MPO)-positive cells. Tissue eosinophilic nasal polyp (ENP) and tissue neutrophilia (Neu) were defined as greater than 70 eosinophils and 20 HNE-positive cells, otherwise was classified into non-eosinophilic nasal polyp (NENP) and absence of tissue neutrophilia (Neu).

Results: In terms of disease control status, NENP-Neu patients showed the higher rate of disease control than NENP-Neu and ENP-Neu patients. Linear by linear association demonstrated the trend in refractoriness from NENP-Neu to NENP-Neu or ENP-Neu to ENP-Neu. When multiple logistic regression was performed, tissue neutrophilia (hazard ratio, 4.38; 95% confidence interval, 1.76-10.85) was found as the strongest risk factor for CRSwNP refractoriness. Additionally, exploratory factor analysis revealed that interleukin (IL)-18, interferon-γ, IL-1Ra, tumor necrosis factor-α, oncostatin M, and MPO were associated with good disease control status, whereas IL-36α and IL-1α were associated with refractory disease control status. In subgroup analysis, HNE-positive cells and IL-36α were significantly upregulated in the refractory group ( = 0.0132 and = 0.0395, respectively), whereas MPO and IL-18 showed higher expression in the controlled group ( = 0.0002 and = 0.0009, respectively). Moreover, immunofluorescence analysis revealed that IL-36R⁺HNE⁺-double positive cells were significantly increased in the refractory group compared to the control group. We also found that the ratio of HNE-positive cells to α1 anti-trypsin was increased in the refractory group.

Conclusions: Tissue neutrophilia had an influence on treatment outcomes in the Asian CRSwNP patients. HNE-positive cells and IL-36α may be biomarkers for predicting refractoriness in Asians with CRSwNP. Additionally, imbalances in HNE and α1 anti-trypsin may be associated with pathophysiology of neutrophilic chronic rhinosinusitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875473PMC
http://dx.doi.org/10.4168/aair.2020.12.1.42DOI Listing

Publication Analysis

Top Keywords

tissue neutrophilia
16
hne-positive cells
16
disease control
16
chronic rhinosinusitis
12
nasal polyps
12
control status
12
rhinosinusitis nasal
8
exploratory factor
8
factor analysis
8
immunofluorescence analysis
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!